CKD E-Learning - SGLT-2 inhibitors and CKD - 05.19.21

CKD E-Learning - SGLT-2 inhibitors and CKD - 05.19.21

Share:

Similar Tracks

CKD - eLearning: Hypertension, CKD and supporting home blood pressure monitoring - 09.15.21 BC Renal

EMPA KIDNEY results: Flozins for all CKD with Dr Will Herrington Ottawa Nephrology

Type 2 Diabetes: The Benefits and Cost-Effectiveness of SGLT2 Inhibitors HMP Education

Update on Cystatin C – It’s Time to Change Your Practice – BCR PWR (April 4, 2025) BC Renal

SGLT2 Inhibitors in Acute Heart Failure The Earlier The Better DICTATE AHF Medscape

"American Empire Is in Decline": Economist Richard Wolff on Trump's Trade War & Tariffs Democracy Now!

How SGLT2 Inhibitors Protect The Kidney Conan Liu, M.D.

Elon Musk's Family History in South Africa Reveals Ties to Apartheid & Neo-Nazi Movements Democracy Now!

Peter Attia: Anti-aging Cure No One Talks About! 50% Chance You’ll Die In A Year If This Happens! The Diary Of A CEO

Professor Christoph Wanner - Renoprotective effects of SGLT2 inhibitors At the Limits - Leading Medical Education

KDIGO Diabetes Management in CKD Guideline KDIGO

How does Dapagliflozin work? Understanding SGLT2 inhibitors. Zero To Finals

Renal events in patients receiving Neprilysin inhibitors: a systematic review and meta-analysis ERA - European Renal Association

Types of IV Fluid - Fluid Management ICU Advantage

GFR Decline as a Surrogate Endpoint for Progression of Chronic Kidney Disease Duke Margolis

Chronic Kidney Disease: Essentials SHRI Knowledge Academy

TARPEYO Reduces the Loss of Kidney Function in IgA Nephropathy DocWire

Vitamin K2: The Surprising Benefits From Your Heart to Your Bones Dr. Pradip Jamnadas, MD

11-10-2022 - SGLT2i: Evidence and Mechanisms for a Nephrology-Cardiology Consensus WashU Medicine Department of Medicine

Palliative Kidney Care in BC: New Developments – BCR PWR Feb 2025 BC Renal